AUG 08, 2019 12:17 PM PDT

Gel Reduces Surgical Scarring

WRITTEN BY: Nouran Amin

Scientists have found that spraying a gel on the internal tissues of animal post-surgery has significantly reduced scarring—which can often lead to devastating consequences. The gel—known as PNP 1:10—is a polymer-nanoparticle hydrogel and was originally developed for drug delivery but was instead found to be an effect medication for adhesion prevention than most currently marketed.

"The difference between what we saw after using the gel and what we normally see after surgery was drastic," said Joseph Woo, MD, professor and chair of cardiothoracic surgery and the Norman E. Shumway Professor.

Historical materials used to prevent adhesion ranged from animal membranes to sheets of rubber and mineral oil. Presently, adhesion barriers approved by the Food and Drug Administration are ineffective and difficult to implement and thus are rarely used in post-surgical interventions. Regardless, adhesions form 95% of the time after surgery and although some may be harmless, others can lead to intestinal compression and life-threatening blockages according to the surgical location.

The PNP 1:10 gel study on animals was published in Nature Biomedical Engineering and describes how the gel was used after cardiac surgery on mice and was found to have the ideal tension. "It covers all of the irregular surfaces of the heart, adhering to the tissues, but not to itself," Woo said.

“The gel doesn't prevent tissues from moving around," said Eric Appel, PhD, an assistant professor of materials science and engineering. "It simply provides a physical barrier to keep them from sticking to each other."

Learn more about surgical wound healing:

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 06, 2020
Drug Discovery & Development
How Medieval Medicine Can Conquer Modern Day Infections?
AUG 06, 2020
How Medieval Medicine Can Conquer Modern Day Infections?
One of our current global threats is antibiotic resistance.     As more biofilm-associated infections are ...
AUG 31, 2020
Cancer
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
AUG 31, 2020
Targeting Your Inner Hedgehog to Fight Chemoresistance in Colorectal Cancer
Chemoresistance is a serious problem for many cancer therapies. Solutions to this problem are harder to come by than the ...
SEP 08, 2020
Drug Discovery & Development
New Drug Boosts Bone Growth in Children with Dwarfism
SEP 08, 2020
New Drug Boosts Bone Growth in Children with Dwarfism
A Phase III global clinical trial by the Murdoch Children’s Research Institute (MCRI) has found that a new drug, k ...
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
SEP 15, 2020
Drug Discovery & Development
Turmeric Better than Placebo for Osteoarthritis Pain
SEP 15, 2020
Turmeric Better than Placebo for Osteoarthritis Pain
Researchers from the University of Tasmania in Australia have found that an extract from turmeric is more effective than ...
OCT 16, 2020
Drug Discovery & Development
FDA Warns Against NSAIDs After Week 20 of Pregnancy
OCT 16, 2020
FDA Warns Against NSAIDs After Week 20 of Pregnancy
The US Food and Drug Administration (FDA) has warned against using nonsteroidal anti-inflammatory drugs (NSAIDs) from 20 ...
Loading Comments...